Neurology: Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor is organized by American Academy of Neurology (AAN) and wiill be held from Apr 17, 2018 - Apr 17, 2021.
The target audience for this medical event is physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits.
Upon completion of the article by Hara et al, the participant should be able to:
• Discuss the effect of exposing cultured neurons to anti-N-methyl-
• D-aspartate receptor (NMDAR) receptor antibodies of different classes observed in this study
• Describe the most common clinical presentation of patients in this study with IgG anti-NMDAR antibodies
• State what percentage of healthy control subjects had anti-NMDAR antibodies in this study
Additional details will be posted as soon as they are available.